DeepMed Research

ShengJing Hospital of China Medical University (China Medical University No.2 Ho spital )

🇨🇳China

Country: 🇨🇳China

Ownership: -

Employees: -

Market Cap: -

Website: http://www.sj-hospital.org

Clinical Trials

Palbociclib + Letrozole Versus Epirubicin + Cyclophosphamide and Sequential Docetaxel as Neoadjuvant Chemotherapy

Phase 4

Not yet recruiting

Conditions: Breast Cancer

Interventions: Drug: palbociclib combined with letrozole
Drug: epirubicin combined with cyclophosphamide and sequential docetaxel

First Posted Date: 2019-10-24

Last Posted Date: 2021-07-20

Lead Sponsor: Shengjing Hospital

Target Recruit Count: 152

Registration Number: NCT04137640

Locations: 🇨🇳
Shengjing Hospital of China Medical University, Shenyang, Liaoning, China

Albumin-bound Paclitaxel and Carboplatin Versus Epirubicin and Docetaxel for Triple-negative Breast Cancer

Phase 4

Recruiting

Conditions: Breast Cancer

Interventions: Drug: Albumin-bound paclitaxel combined with carboplatin
Drug: Epirubicin combined with docetaxel

First Posted Date: 2019-10-23

Last Posted Date: 2021-07-20

Lead Sponsor: Shengjing Hospital

Target Recruit Count: 110

Registration Number: NCT04136782

Locations: 🇨🇳
The Second Hospital of Jilin University, Changchun, Jilin, China
🇨🇳
Shengjing Hospital of China Medical University, Shenyang, Liaoning, China
🇨🇳
The Fourth Affiliated Hospital of China Medical University, Shenyang, Liaoning, China

and more 4 locations

Effect of Transcutaneous Electrical Acupoint Stimulation on Sleep After Thoracoscopic Surgery

Not Applicable

Completed

Conditions: Thoracoscopic Surgery
Postoperative Sleep Quality
Transcutaneous Electrical Acupoint Stimulation

Interventions: Other: Transcutaneous Electrical Acupoint Stimulation

First Posted Date: 2019-10-11

Last Posted Date: 2020-08-27

Lead Sponsor: Shengjing Hospital

Target Recruit Count: 78

Registration Number: NCT04124679

Locations: 🇨🇳
Shengjing hospital of China Medical university, Shenyang, Liaoning, China

Comparison of Effects of Oxycodone and Sufentanil on Cardiovascular Stress Induced by Tracheal Intubation in the Patients With Coronary Heart Disease Undergoing Major Noncardiac Surgery

Not Applicable

Completed

Conditions: Cardiovascular

Interventions: Drug: Oxycodone 10mg
Drug: Sufentanil

First Posted Date: 2019-10-09

Last Posted Date: 2019-10-09

Lead Sponsor: Shengjing Hospital

Target Recruit Count: 50

Registration Number: NCT04121416

Locations: 🇨🇳
shengjing hospital of China medical university, Shenyang, Liao Ning, China

Comparison of Morning Operation and Evening Operation on Postoperative Sleep Quality and Pain Under General Anesthesia

Not Applicable

Completed

Conditions: Morning Operation
Circadian Rhythm Sleep Disorder
Evening Operation
General Anesthesia
Sleep Quality

Interventions: Other: receiving operation during the day or at night

First Posted Date: 2019-09-18

Last Posted Date: 2020-04-24

Lead Sponsor: Shengjing Hospital

Target Recruit Count: 84

Registration Number: NCT04094376

Locations: 🇨🇳
Shengjing hospital of China Medical University, Shenyang, Liaoning, China

Circulating Tumor Cell Detection in Patients With Luminal A Breast Cancer

Recruiting

Conditions: Breast Neoplasms

Interventions: Procedure: PET-CT examination
Procedure: Peripheral blood detection

First Posted Date: 2019-08-22

Last Posted Date: 2022-05-05

Lead Sponsor: Shengjing Hospital

Target Recruit Count: 500

Registration Number: NCT04065321

Locations: 🇨🇳
Cancer Hospital of China Medical University, Liaoning Cancer Hospital and Institute, Shenyang, Liaoning, China
🇨🇳
Shengjing Hospital of China Medical University, Shenyang, Liaoning, China

CTC Changes and Efficacy of Neoadjuvant Chemotherapy for Triple-negative Breast Cancer

Recruiting

Conditions: Breast Neoplasms

Interventions: Drug: Taxanes or/and anthracycline-based therapy

First Posted Date: 2019-08-16

Last Posted Date: 2022-01-20

Lead Sponsor: Shengjing Hospital

Target Recruit Count: 200

Registration Number: NCT04059003

Locations: 🇨🇳
Cancer Hospital of China Medical University, Liaoning Cancer Hospital and Institute, Shengyang, Liaoning, China
🇨🇳
Shengjing Hospital of China Medical University, Shenyang, Liaoning, China

DFS and QOL After Modified Radical Mastectomy vs. Expanded Mckissock Surgery for EIC of the Breast

Not Applicable

Recruiting

Conditions: Breast Neoplasms

Interventions: Procedure: Modified radical mastectomy
Procedure: Expanded Mckissock surgery

First Posted Date: 2019-08-12

Last Posted Date: 2022-02-08

Lead Sponsor: Shengjing Hospital

Target Recruit Count: 200

Registration Number: NCT04052893

Locations: 🇨🇳
Cancer Hospital of China Medical University, Liaoning Cancer Hospital and Institute, Shengyang, Liaoning, China
🇨🇳
General Hospital of Benxi Iron & Steel Industry Group of Liaoning Health Industry Group, Benxi, Liaoning, China
🇨🇳
Shengjing Hospital of China Medical University, Shenyang, Liaoning, China

Palbociclib Combined With an Aromatase Inhibitor in Breast Cancer

Phase 3

Conditions: Breast Cancer

Interventions: Drug: Palbociclib + Letrozole
Drug: Letrozole

First Posted Date: 2019-08-07

Last Posted Date: 2021-07-20

Lead Sponsor: Shengjing Hospital

Target Recruit Count: 420

Registration Number: NCT04047758

Locations: 🇨🇳
Liaoning Cancer Hospital & Institute, Shenyang, Liaoning, China
🇨🇳
Liaoning Provincial People's Hospital, Shenyang, Liaoning, China
🇨🇳
Shengjing Hospital of China Medical University, Shenyang, Liaoning, China

Study on Bisphosphonates Targeting Triple-negative Breast Cancer

Conditions: Breast Cancer

First Posted Date: 2019-08-05

Last Posted Date: 2021-07-20

Lead Sponsor: Shengjing Hospital

Target Recruit Count: 120

Registration Number: NCT04045522

Locations: 🇨🇳
People's Hospital of Liaoning Province, Shenyang, Liaoning, China
🇨🇳
Liaoning Tumor Hospital & Institute, Shenyang, Liaoning, China
🇨🇳
Shengjing Hospital of China Medical University, Shenyang, Liaoning, China

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy